| Verified against primary record | |
| The clearest conditioned incentive | Qualified healthcare travellers must be at least 10 per cent of total patients each year of assessment[1] |
|---|---|
| What it granted | Income tax exemption equivalent to an investment tax allowance of 100 per cent of qualifying capital expenditure[1] |
| A free-zone tax provision | A zero tax rate for fifty years, covering all taxes including income tax, plus customs exemption[2] |
| Records read | An investment authority guideline and page, an emirate law, a national strategy and two peer-reviewed studies, 9 October 2026 |
| Independently reported | |
| A published critique | Subsidising private sector growth through tax breaks and land access is unlikely to benefit the health system at large[4] |
| Bands apply only to the rows beneath them. The incentive described in the first rows and its current status are reported from two documents that disagree, and both dates are given. | |
Medical tourism and public subsidies is the question of what states contribute to a sector usually described as private. The answer, where instruments can be read, is a good deal: free-zone tax holidays, investment allowances, concessional import duties, promotion agencies and national marketing brands. One instrument conditions the benefit explicitly on treating foreign patients.
An incentive tied directly to foreign patients
The strongest instrument located is an investment authority guideline on a tax incentive for the promotion of healthcare travel, dated 6 May 2021. It granted an income tax exemption equivalent to an investment tax allowance of 100 per cent on qualifying capital expenditure incurred within a period of five years, offsettable against all statutory income with the unused balance carried forward.[1]
Its conditions are the interesting part. Qualified healthcare travellers had to comprise at least 10 per cent of the facility’s total patients for each year of assessment, with a parallel condition on gross income, and the facility had to be registered with the national healthcare travel promotion body.[1] That is a public benefit made contingent on a quantified share of foreign caseload, which is the clearest documented case of a state paying for international patient volume.
Its current status is unclear from the authority’s own material, and the ambiguity should be reported rather than resolved. The authority’s healthcare services page states that income tax exemption incentives for private healthcare facilities expired on 1 January 2023, while describing a double deduction on quality accreditation costs for facilities registered with the promotion body and an automation capital allowance of 200 per cent on the first 10 million ringgit of expenditure for the years of assessment 2023 to 2027.[3] The guideline and the page disagree, so any claim about these incentives has to carry its date.
The promotion body itself describes its status plainly, as an agency under the health ministry entrusted with facilitating and promoting the healthcare travel industry. A patient volume figure on its corporate page is undated marketing material and is treated here as provider-supplied rather than reproduced.
Free-zone treatment, which is not the same thing
One emirate’s healthcare city law provides that establishments within it and their employees will be subject to a zero tax rate for fifty years, renewable by resolution, covering all taxes including income tax on their operations in the zone, and that goods imported into or used within the zone are exempt from customs duties. The authority retains power to impose and collect fees for the services it provides.[2]
That is a substantial fiscal privilege, and it is not a medical tourism subsidy in the sense above. It is free-zone treatment available to establishments inside the zone regardless of whether they treat foreign patients, with no condition on foreign caseload. The distinction matters when such provisions are cited as evidence that a state subsidises medical tourism specifically.
Promotion, assistance and duties
A third pattern is promotional and administrative rather than fiscal. One national strategy records that the tourism ministry will make its market development assistance scheme more attractive, proposes that import of equipment and other consumables may be allowed at concessional duties in the enclaves it envisages, notes the constitution of a national medical and wellness tourism board, and states that the country will be marketed as a medical and wellness tourism destination under a named national brand.[5]
Three limits on that document. It states no subsidy amounts. It gives no government marketing budget figure. And its duty concession is conditional and tied to enclaves the document only proposes. No published figure for any government’s medical tourism marketing budget was located for this entry.
The published objections
Two peer-reviewed sources set out the case against this form of support, and both are specific about the mechanism.
A comparative study of three destinations states that government subsidies for private sector growth, via tax breaks and preferential access to land, is unlikely to benefit the health system at large, observes that governments are noticeably playing a strong marketing and promotional role in the emerging medical tourism industry, and makes the training point directly: medical education is largely publicly funded, and private hospitals do not share the costs of such education. It frames financial benefits as something that may come at the expense of access.[4]
A paper in the World Health Organization’s bulletin goes further on remedy, stating that with their much higher purchasing power medical tourists can prevent taxpayers from accessing quality health care, that the government has strong grounds for levying a tax on medical tourists, and that most developing country governments see medical tourism as an opportunity to generate more national income.[6] Both papers are from 2011.
The underlying asymmetry both describe is simple enough to state without either source: the state pays to train the clinician and may forgo tax on the facility that employs them, while the revenue accrues privately. Whether that exchange is favourable depends on figures that, as set out in medical tourism and local access to care, nobody has.
See also
- Medical tourism clusters, the zones these privileges attach to
- Medical tourism and foreign investment, who may own the facilities
- Medical tourism and local access to care, the distributional question
- Medical tourism and health workforce migration, who paid for the training
References
- Malaysian Investment Development Authority. Guideline on application for tax incentive for the promotion of healthcare travel. Dated 6 May 2021. Verified against primary record: the incentive, its quantified foreign-patient condition and the registration requirement were read in the guideline. Retrieved 9 October 2026.
- Government of Dubai. Law No. 16 of 2024 concerning the Dubai Healthcare City. Dubai Legislation Portal. Verified against primary record: the tax and customs articles and the authority’s fee power were read. Retrieved 9 October 2026.
- Malaysian Investment Development Authority. Healthcare services. Page modified 5 June 2026. Verified against primary record: the stated expiry, the accreditation deduction and the automation allowance were read; this page and the 2021 guideline disagree on whether the exemption is current. Retrieved 9 October 2026.
- Pocock NS, Phua KH. Medical tourism and policy implications for health systems, a conceptual framework from a comparative study of Thailand, Singapore and Malaysia. Globalization and Health, 2011;7:12. Independently reported: peer-reviewed study read. Retrieved 9 October 2026.
- Ministry of Tourism, Government of India. National strategy and roadmap for medical and wellness tourism. 2022. Verified against primary record: the assistance scheme, duty concession proposal, board constitution and national brand were read; no subsidy amounts or marketing budget appear in the document. Retrieved 9 October 2026.
- NaRanong A, NaRanong V. The effects of medical tourism, Thailand’s experience. Bulletin of the World Health Organization, 2011;89:336-344, published online 28 February 2011. Independently reported: peer-reviewed paper in a World Health Organization journal. Retrieved 9 October 2026.
Sourcing note: the investment authority guideline and services page, the emirate law, the national strategy and the two peer-reviewed studies were opened and read on 9 October 2026. The guideline and the authority’s current page disagree on whether the income tax exemption is live, and both are reported with their dates rather than reconciled. The free-zone tax provision is distinguished from an incentive conditioned on foreign patients, because the two are commonly cited together. No government marketing budget figure for this sector was located, and no Thai statutory instrument granting incentives for foreign patients was found; both are search results rather than proof of absence. Both critiques are from 2011 and are dated in the text.